Is Haleon plc (HLNCF) a Buy, Sell, or Hold?
OTC : HLNCF
Haleon plc
$4.95 USD
$0.1 (2.04%)
- Volume
- 403
- Average Volume
- 26.87K
- Market Capitalization
- $43.6B
- P/E Ratio
- 19.86
- Dividend Yield
- 1.93%
- Price Target
- Year High
- $5.75
- Year Low
- $4.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.37
- Current Ratio
- $0.92
Company Overview
OTC
Brian James McNamara
Drug Manufacturers - Specialty & Generic
Healthcare
HLNCF
24561
GB
USD
Liquidity Metrics
0.52
0.92
0.71
0.27
0.37
Sales & Valuation
$11.03B
2.94
2.01
27.42
0.13
Profitability
$0.19
$1.67B
15.11%
19.51%
10.30%
5.11%
P/E Metrics
19.86
1.06
1.06
Analyst Price Target & Rating
2/5
1 Analysts
%
Financial Health Scores
2.89
7/9
-$383M
$32.63B
$16.15B
$2.32B
Key Metrics (TTM)
$39.94B
3.62
14.25
0.92
10.30%
6.60%
5.01%
3.62%
$2.77
-184 days
Company Executives
| Name | Title |
|---|---|
| Keith Choy | President of Asia Pacific |
| Claire Dickson | Chief Digital & Technology Officer |
| Dawn Amanda Allen | Chief Financial Officer & Director |
| Joanne Russell | Head of Investor Relations |
| Line De Decker | Chief Human Resources Officer |
| Tamara Rogers | Chief Marketing Officer |
| Filippo Lanzi | President of EMEA & LatAm |
| Bjorn Timelin | Head of Strategy |
| Adrian Charles Morris | General Counsel |
| Brian James McNamara | Chief Executive Officer & Executive Director |
Poll Results
No votes yet today — be the first to share your view!
About Haleon plc (OTC:HLNCF) Stock
Haleon plc operates as a global consumer healthcare enterprise, actively involved in the research, development, production, and distribution of a diverse range of products. Its business activities cover extensive regions, including North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers various solutions such as oral hygiene products, pain management remedies, respiratory care items, digestive health aids, and a selection of vitamins, minerals, and supplements. Its notable brand collection features Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially named DRVW 2022 plc before officially rebranding to Haleon plc in February 2022. Its main office is situated i ... n Brentford, United Kingdom.
Frequently Asked Questions
-
What is the current Haleon plc (HLNCF) stock price?
-
Haleon plc(OTC:HLNCF) stock price is $4.95 in the last trading session. During the trading session, HLNCF stock reached the peak price of $5.75 while $4.15 was the lowest point it dropped to. The percentage change in HLNCF stock occurred in the recent session was 2.04% while the dollar amount for the price change in HLNCF stock was $0.1.
-
HLNCF's industry and sector of operation?
-
The OTC listed HLNCF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of HLNCF?
-
Keith Choy | President of Asia Pacific
Claire Dickson | Chief Digital & Technology Officer
Dawn Amanda Allen | Chief Financial Officer & Director
Joanne Russell | Head of Investor Relations
Line De Decker | Chief Human Resources Officer -
How many employees does HLNCF have?
-
Number of HLNCF employees currently stands at 24561. HLNCF operates from Building 5, Weybridge, SU KT13 0NY, GB.
-
Link for HLNCF official website?
-
Official Website of HLNCF is: https://www.haleon.com
-
How do I contact HLNCF?
-
HLNCF could be contacted at phone #44 1932 822000 and can also be accessed through its website. HLNCF operates from Building 5, Weybridge, SU KT13 0NY, GB.
-
How many shares of HLNCF are traded daily?
-
The average number of HLNCF shares traded daily for last 3 months was 26.87K.
-
What is the market cap of HLNCF currently?
-
The market value of HLNCF currently stands at $43.6B with its latest stock price at $4.95